ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,765,000 | +52.9% | 141,892 | +68.3% | 0.00% | 0.0% |
Q3 2016 | $1,154,000 | +113.3% | 84,296 | +15.1% | 0.00% | +100.0% |
Q2 2016 | $541,000 | +26.1% | 73,249 | +9.2% | 0.00% | 0.0% |
Q1 2016 | $429,000 | -34.6% | 67,094 | -36.1% | 0.00% | 0.0% |
Q4 2015 | $656,000 | -72.1% | 104,995 | -73.9% | 0.00% | -80.0% |
Q3 2015 | $2,352,000 | -30.7% | 402,812 | -1.8% | 0.01% | -28.6% |
Q2 2015 | $3,393,000 | -26.6% | 410,278 | -26.9% | 0.01% | -22.2% |
Q1 2015 | $4,625,000 | +20.3% | 561,274 | +0.3% | 0.01% | +12.5% |
Q4 2014 | $3,845,000 | +21.6% | 559,620 | -4.5% | 0.01% | +14.3% |
Q3 2014 | $3,163,000 | -8.9% | 585,741 | +7.4% | 0.01% | -12.5% |
Q2 2014 | $3,473,000 | -13.0% | 545,255 | +10.1% | 0.01% | -11.1% |
Q1 2014 | $3,991,000 | +21.9% | 495,164 | +3.1% | 0.01% | +12.5% |
Q4 2013 | $3,275,000 | +181.1% | 480,268 | +658.3% | 0.01% | +166.7% |
Q3 2013 | $1,165,000 | +35.6% | 63,333 | +29.0% | 0.00% | 0.0% |
Q2 2013 | $859,000 | – | 49,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |